IMODIUM MULTI-SYMPTOM RELIEF OTC
Generic Name and Formulations:
Loperamide HCl 2mg, simethicone 125mg; chew tabs; caplets; mint flavored; contains calcium.
McNeil Consumer Healthcare
Indications for IMODIUM MULTI-SYMPTOM RELIEF:
Diarrhea with gas.
Chew tabs: take with 4–8oz of water after each dose. Initially 2 chew tabs or caplets, then 1 chew tab or caplet after each loose stool; max 4 tabs or caplets per day for 2 days.
<6yrs: consult physician. Chew tabs: take with 4–8oz of water after each dose. ≥6yrs: initially 1 chew tab or caplet, then ½ chew tab or caplet after each loose stool. 48–59lbs (6–8yrs): max 2 tabs or caplets per day for 2 days. 60–95lbs (9–11yrs): max 3 tabs or caplets per day for 2 days.
If constipation must be avoided. Acute dysentery.
Acute ulcerative colitis and antibiotic induced pseudomembranous colitis; discontinue if abdominal distention occurs. In dehydration, use fluid and electrolyte replacement. Hepatic dysfunction; monitor for CNS toxicity. Pregnancy (Cat.B). Nursing mothers.
Antidiarrheal + antiflatulent.
Abdominal pain, distention, constipation, dry mouth, nausea, drowsiness, dizziness, fatigue, rash.
Caps—30; A-D Caplets—6, 12, 18, 24; A-D Liq—2oz, 4oz; Multi-Symptom Caplets—12, 42; Multi-Symptom Chew tabs—18, 42
Clinical Pain Advisor Articles
- Analyzing Coverage of Nonpharmacologic Treatments for Low Back Pain
- Smartphone App Helps Evaluate Catastrophizing in Chronic Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Dozens of Medical Groups Join Forces to Improve Diagnoses
- FDA Grants Non-Opioid Analgesic VVZ-149 Fast Track Status
- Little to No Association Found Between Physician Performance and Medical School Ranking